SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-048271
Filing Date
2014-02-12
Accepted
2014-02-12 16:45:33
Documents
1
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G d677702dsc13g.htm SC 13G 43496
  Complete submission text file 0001193125-14-048271.txt   44988
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87481 | Film No.: 14600938
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 908-673-9000
Celgene European Investment Co LLC (Filed by) CIK: 0001577650 (see all company filings)

IRS No.: 900587060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G